https://www.selleckchem.com/products/azd4573.html
The DP score showed a clinically useful predictive performance for T2D remission at 3years after surgery [training cohort area under the receiver operating characteristics (AUROC) 0.73, 95% confidence interval (CI), 0.71-0.75; validation cohort AUROC 0.72, 95% CI 0.69-0.75], which was comparable to that of the machine-learning models (random forest AUROC 0.71, 95% CI 0.68-0.74; XGboost AUROC 0.70, 95% CI 0.67-0.73; LASSO regression AUROC 0.75, 95% CI 0.73-0.78 in the validation cohort). It also predicted the T2D remission at 6 and 9year